-
Research HighlightDecember 06, 2023The influence of viral DNA on Type 1 diabetes
David Serreze is researching the potential viral influence on Type 1 diabetes. -
Profile StoryMay 04, 2023Meet Rei Bufi, postbaccalaureate associate
A 5-question chat with up-and-coming JAX researcher Rei Bufi. -
Research HighlightJuly 15, 2022Immune regulation dysfunction contributes to diabetes
David Serreze's latest paper, published in the Journal of Immunology, was named a Top Read in the July issue for its findings regarding a protective mechanism against type 1 diabetes in an important mouse model for the disease. -
Research HighlightFebruary 15, 2022JAX researchers are delaying kidney failure
Ron Korstanje at JAX is searching for genetic clues to slowing the progress of end-stage renal disease in patients with Alport syndrome and other kidney diseases.
-
Research HighlightOctober 17, 2023Potential early sign of Type 2 diabetes identified
Michael Stitzel, Ph.D., is advancing the understanding of Type 2 diabetes and its risk identifiers, which now include dysfunction in the powerhouse of the cell, the mitochondria. -
Research HighlightApril 11, 2023Churchill Lab performs multi-omics study on protein phosphorylation regulators
The Churchill lab performed an integrative multi-omics analysis of 58 genetically diverse Collaborative Cross strains to identify regulators of protein phosphorylation. -
Featured ArticleApril 05, 2022Making sense of the universe in three dimensions
glue solutions inc., a firm specializing in data science and visualization, grew out of a project to visualize astronomy data and is now working with JAX to do the same for genomics, providing ways to bring the genetic data to life. -
Research HighlightNovember 09, 2021JAX researchers examine genetic susceptibility to type 2 diabetes
Type 2 diabetes, a major health problem throughout much of the world, is being targeted on a genetic level by JAX researchers.
